Second, XPR1 down-regulation used gene silencing technology, and did not use gene editing technology; third, the animal experiment used nude mouse subcutaneous tumor formation technology and did not use ovarian cancer in situ tumor technology, which cannot reflect the abdominal metastasis process of ovarian cancer. The gene discussed is XPR1; the disease is ovarian carcinoma.